Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
Delayed Nasdaq  -  04:00:00 2023-03-24 pm EDT
128.20 USD   -0.92%
03/23HC Wainwright Adjusts BioNTech's Price Target to $210 From $272, Keeps Buy Rating
MT
03/22China approves its first mRNA vaccine, from domestic drugmaker CSPC
RE
03/21U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJ
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BIONTECH SE
03/23HC Wainwright Adjusts BioNTech's Price Target to $210 From $272, Keeps Buy Rating
MT
03/20BioNTech to jointly develop novel antibody for cancers
AQ
03/20BioNTech, OncoC4 to Develop, Commercialize ONC-392 as Therapy in Various Cancer Indicat..
MT
03/20BioNTech SE and OncoC4, Inc. Announce Strategic Collaboration to Co-Develop and Commerc..
CI
03/20BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize No..
GL
03/20BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize No..
AQ
03/15BioNTech, Pfizer Receive Emergency Use Authorization for Bivalent COVID-19 Vaccine in C..
MT
03/15Biontech : Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA..
PU
03/15Pfizer Inc. and BioNTech SE Receives U.S. Emergency Use Authorization of Omicron BA.4 B..
CI
03/15Rwanda Welcomes Africa's First Mobile Vaccine-Production Units
AQ
03/13BioNTech Advances Development of mRNA Vaccine Making Facility in Rwanda
MT
03/13BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational ..
GL
03/13BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational ..
AQ
03/06Protection From Updated Bivalent COVID-19 Vaccines May Start to Fade After Two Months, ..
MT
03/01BioNTech to Collaborate With Israel's Weizmann Institute on Disease Research
MT
More most relevant news
All news about BIONTECH SE
03/23HC Wainwright Adjusts BioNTech's Price Target to $210 From $272, Keeps Buy Rating
MT
03/22China approves its first mRNA vaccine, from domestic drugmaker CSPC
RE
03/21U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJ
RE
03/20Moderna expects to price its COVID vaccine at about $130 in the US
RE
03/20BioNTech to jointly develop novel antibody for cancers
AQ
03/20BioNTech, OncoC4 to Develop, Commercialize ONC-392 as Therapy in Various Cancer Indicat..
MT
03/20BioNTech SE and OncoC4, Inc. Announce Strategic Collaboration to Co-Develop and Commerc..
CI
03/20BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize No..
GL
03/20BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize No..
AQ
03/15BioNTech, Pfizer Receive Emergency Use Authorization for Bivalent COVID-19 Vaccine in C..
MT
More news
News in other languages on BIONTECH SE
12:40pWOCHENVORSCHAU: Termine bis 7. April 2023
12:39pTAGESVORSCHAU: Termine am 27. März 2023
11:37aBeursagenda: buitenlandse fondsen
10:57a6 TERMINE, die in der Woche wichtig werden
09:57aTAGESVORSCHAU/Samstag, 25. bis Montag, 27. März (vorläufige Fassung)
09:52aWOCHENVORSCHAU/27. März bis 2. April (13. KW)
01:55aBeursagenda: buitenlandse fondsen
01:05aWOCHENVORSCHAU: Termine bis 6. April 2023
03/23Beursagenda: buitenlandse fondsen
03/23Beursagenda: buitenlandse fondsen
More news
Analyst Recommendations on BIONTECH SE
03/23HC Wainwright Adjusts BioNTech's Price Target to $210 From $272, Keeps Buy Rating
MT
02/01BIONTECH : UBS remains Neutral
MD
01/31Goldman Sachs Adjusts Price Target on BioNTech SE to $156 From $177, Maintains Neutral ..
MT
01/30BIONTECH : Gets a Buy rating from Berenberg
MD
01/30Berenberg Bank Adjusts BioNTech SE's Price Target to $300 From $312, Maintains Buy Rati..
MT
More recommendations
Press releases
03/20BioNTech to jointly develop novel antibody for cancers
AQ
03/20BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize No..
GL
03/20BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize No..
AQ
03/15Biontech : Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA..
PU
03/15Rwanda Welcomes Africa's First Mobile Vaccine-Production Units
AQ
More press releases
Analysis
Drug companies face COVID cliff in 2023 as sales set to plummet
Upcoming event on BIONTECH SE
03/27/23FY 2022 Earnings Call
Upcoming sector events
05/02/23WUXI APPTEC CO., LTD. : Q1 2023 Earnings Release (Projected)
05/03/23VERTEX PHARMACEUTICALS INCORPORATED : Q1 2023 Earnings Release (Projected)
05/04/23REGENERON PHARMACEUTICALS, INC. : Q1 2023 Earnings Release (Projected)
05/10/23GENMAB A/S : Q1 2023 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Stock markets for all
100% Free Registration
fermer